Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Allergenis
AddedFeb 16, 2024
UpdatedJun 18, 2026
Allergenis

Allergenis

Seed

AllerGenis: Precision data analytics for detecting & managing immune disorders, with a focus on food allergies.

HQ
Hatfield, PA, US
Founded
2017
Overview
Compare
Fundraising
Employees
Website

AllerGenis is a precision data analytics company founded with the mission to revolutionize the detection and management of life-threatening immune response disorders, particularly food allergies. Leveraging the world’s largest database of phenotypic patient data derived from epitope mapping, clinical history, and patient-reported outcomes, AllerGenis aims to provide healthcare providers with accurate, data-driven diagnostics. Their primary product focuses on redefining food allergy testing, starting with peanut allergies, to offer more precise and safer diagnostic solutions.

Notable figures affiliated with AllerGenis include leading experts in immunology and data science, though specific names are not provided. The company has attracted significant interest from investors focused on healthcare innovation. Key achievements include the development of their advanced diagnostic platform and the successful integration of extensive patient data to enhance clinical insights. AllerGenis has made a substantial impact by improving the accuracy of food allergy diagnoses, thereby enhancing patient care and safety.

Allergenis - Similar Companies

Alerje logo

Alerje

alerje.com

IngateyGen logo

IngateyGen

ingateygen.com

Allergy Amulet logo

Allergy Amulet

allergyamulet.com

Allermi logo

Allermi

Allergood logo

Allergood

Nectar Life Sciences logo

Nectar Life Sciences

Alladapt Immunotherapeutics logo

Alladapt Immunotherapeutics

alladapt.com

Allelica logo

Allelica

allelica.com

Predictive Health Diagnostics Company logo

Predictive Health Diagnostics Company

PanGenX logo

PanGenX

AllerPops logo

AllerPops

allerpops.com

Probably Genetic logo

Probably Genetic

HI-Bio logo

HI-Bio

hibio.com

Alrgn Bio logo

Alrgn Bio

Arrow Allergy logo

Arrow Allergy

arrowallergy.com

Allergenis - Quick Facts

Who are Allergenis' competitors?

Companies similar to Allergenis include Alerje, IngateyGen, Allergy Amulet and Allermi.

When was Allergenis founded?

Allergenis was founded in 2017.

Where is Allergenis' headquarters located?

Allergenis' headquarters is located in Hatfield, PA, US.

When was Allergenis' last funding round?

Allergenis' most recent funding round was for $15M (USD) in November 2017.

How much has Allergenis raised to-date?

As of Nov 1, 2017, Allergenis has raised a total of $15M (USD).

How many employees does Allergenis have?

Allergenis has 38 employees as of Feb 5, 2024.

Allergenis - Classification

Ownership
  • Private
Technology
  • AI
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Data Analytics
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 9 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 620000Health Care and Social Assistance
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 7372Prepackaged Software
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified